Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 16/20 | 0.76 |
| ▸ | EGFR | P00533 | 1/20 | 0.68 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.68 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.68 |
| ▸ | JAK2 | O60674 | 1/20 | 0.67 |
| ▸ | FLT3 | P36888 | 1/20 | 0.67 |
| ▸ | SYK | P43405 | 1/20 | 0.65 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL270435 | 0.87 | BRD4 (0.76) | BRD4EGFR | |
| SCHEMBL12278146 | 0.87 | BRD4 (0.68) | BRD4EGFRJAK2FLT3ALK | |
| SCHEMBL12111070 | 0.86 | BRD4 (0.73) | BRD4EGFRJAK2FLT3 | |
| Hydrochloric Acid SCHEMBL266755 | 0.86 | BRD4 (0.74) | BRD4EGFR | |
| SCHEMBL17526244 | 0.86 | BRD4 (1.00) | BRD4EGFR | |
| SCHEMBL30306570 | 0.86 | BRD4 (1.00) | BRD4EGFR | |
| SCHEMBL24426202 | 0.86 | SYK (0.62) | BRD4PDGFRBPDGFRASYK | |
| SCHEMBL270552 | 0.85 | BRD4 (0.80) | BRD4EGFRALK | |
| SCHEMBL17915974 | 0.84 | BRD4 (0.78) | BRD4JAK2FLT3ALK | |
| SCHEMBL12277255 | 0.84 | PDGFRB (0.69) | BRD4PDGFRBPDGFRASYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673149-A1 | NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA | Trustlife Global Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024179699-A1 | NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA | BASH BIOTECH INC. (US) | 2024-09-06 | — | — | WO | disclosed |